NCT03096405

Impact MRSA -PCR on Patient Management

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 50 (actual)
• Sponsor: Fondation Hôpital Saint-Joseph · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Staphylococcus aureus represents one of the most met germs, with Escherichia coli, during bacteremia. Microbiologist distinguish at aureus S. two profiles of resistance in beta-lactamines: S. aureus sensitive to the methicillin ( SASM) and the S. aureus resistant to the methicillin ( SARM). With the implementation of the MALDI-TOF, it is now possible to identify the origin responsible of the bacteremia the day of the positivity of the hemoculture ( J0) and to set up a treatment with adapted antibiotic, which, in the case of a sepsis to aureus S., is the vancomycine. Ye it was demonstrated, that the use of the vancomycine on the SASM increased the average duration of stay and a more important rate of relapse. The PCR SARM was organized in the GHPSJ in 2014. It allows from the day of the positivity of the hemoculture ( J0), to determine the phenotype of resistance of S. aureus.

Conditions

• MRSA Bacteremia

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Polymerase Chain Reaction of Methicillin Resistant Staphyloccus Aureus	Polymerase Chain Reaction of Methicillin Resistant Staphyloccus Aureus

Timeline

• Start date: 2014-02-01
• Primary completion: 2016-03-31
• Completion: 2017-02-28
• First posted: 2017-03-30
• Last updated: 2017-05-30

Locations

1 site across 1 country: France